Results:According to CHD the incidence of hypotension is 48.6%,PHD is 40%,take midodrine orally is 46.2%,There were no significantly differences to group①(P＞0.05).
结果:常规透析组患者低血压的发生率为48.6%,使用米多君模式、钠曲线超滤曲线模式低血压的发生率明显降低,分别为46.2%和40%,但与常规透析模式相比无统计学差异(P＞0.05)。
参考来源 - 可调钠曲线与超滤曲线及口服米多君预防透析相关低血压的研究·2,447,543篇论文数据，部分数据来源于NoteExpress
Conclusion: Midodrine is effective in treatment of hemodialysis associated hypotension.
结论：米多君治疗血液透析相关性低血压有效且安全。
Objective to evaluate the efficacy and tolerability of midodrine (Gutron) in female patients with stress incontinence.
目的评价盐酸米多君(管通)治疗女性压力性尿失禁的有效性和安全性。
AbstractObjectiveTo determine whether midodrine hydrochloride therapy could prevent vasovagal syncope (VVS) in pediatric patients.
目的探讨米多君对血管迷走性晕厥儿童的治疗效果。
应用推荐